APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hematopoietic Stem Cells Transplantation

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.

Selected research

Market Outlook & Growth Opportunities

Global Hematopoietic Stem Cells Transplantation Market Outlook and Growth Opportunities 2026

Report ID 173894400427 December 2025194 pages

Choose your research edition.

Industry ResearchHematopoietic Stem Cells Transplantation Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Hematopoietic Stem Cells Transplantation Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Hematopoietic Stem Cells Transplantation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hematopoietic Stem Cells Transplantation Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Hematopoietic Stem Cells Transplantation Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.

Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.

This report provides an overview of the global Hematopoietic Stem Cells Transplantation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Hematopoietic Stem Cells Transplantation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hematopoietic Stem Cells Transplantation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Hematopoietic Stem Cells Transplantation market.

Hematopoietic Stem Cells Transplantation Segment by Company

CBR Systems

China Cord Blood Corporation

ViaCord

Thermo Fisher Scientific

STEMCELL Technologies

Vcanbio

Merck Millipore

Lonza Group

CellGenix Technologie Transfer

ThermoGenesis

Hematopoietic Stem Cells Transplantation Segment by Type

Stem Cells Storage

Stem Cells Consumables

Hematopoietic Stem Cells Transplantation Segment by Application

Leukemia

Lymphoproliferative Disorders

Solid Tumors

Non-Malignant Disorders

Hematopoietic Stem Cells Transplantation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hematopoietic Stem Cells Transplantation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Hematopoietic Stem Cells Transplantation key companies, revenue, market share, and recent developments.

3. To split the Hematopoietic Stem Cells Transplantation breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Hematopoietic Stem Cells Transplantation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hematopoietic Stem Cells Transplantation significant trends, drivers, influence factors in global and regions.

6. To analyze Hematopoietic Stem Cells Transplantation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hematopoietic Stem Cells Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hematopoietic Stem Cells Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hematopoietic Stem Cells Transplantation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hematopoietic Stem Cells Transplantation industry.

Chapter 3: Detailed analysis of Hematopoietic Stem Cells Transplantation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Hematopoietic Stem Cells Transplantation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Hematopoietic Stem Cells Transplantation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hematopoietic Stem Cells Transplantation Industry Trends Table 2. Hematopoietic Stem Cells Transplantation Industry Drivers Table 3. Hematopoietic Stem Cells Transplantation Industry Opportunities and Challenges Table 4. Hematopoietic Stem Cells Transplantation Industry Restraints Table 5. Global Hematopoietic Stem Cells Transplantation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hematopoietic Stem Cells Transplantation Revenue Share by Company (2021-2026) Table 7. Global Hematopoietic Stem Cells Transplantation Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Hematopoietic Stem Cells Transplantation Key Company Manufacturing Base & Headquarters Table 9. Global Hematopoietic Stem Cells Transplantation Company, Product Type & Application Table 10. Global Hematopoietic Stem Cells Transplantation Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Hematopoietic Stem Cells Transplantation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Stem Cells Storage Table 15. Significant Companies of Stem Cells Consumables Table 16. Global Hematopoietic Stem Cells Transplantation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Hematopoietic Stem Cells Transplantation Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Hematopoietic Stem Cells Transplantation Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Hematopoietic Stem Cells Transplantation Sales Value Share by Type (2021-2026) Table 20. Global Hematopoietic Stem Cells Transplantation Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Leukemia Table 22. Significant Companies of Lymphoproliferative Disorders Table 23. Significant Companies of Solid Tumors Table 24. Significant Companies of Non-Malignant Disorders Table 25. Global Hematopoietic Stem Cells Transplantation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Hematopoietic Stem Cells Transplantation Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Hematopoietic Stem Cells Transplantation Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Hematopoietic Stem Cells Transplantation Sales Value Share by Application (2021-2026) Table 29. Global Hematopoietic Stem Cells Transplantation Sales Value Share by Application (2027-2032) Table 30. Global Hematopoietic Stem Cells Transplantation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Hematopoietic Stem Cells Transplantation Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Hematopoietic Stem Cells Transplantation Sales Value Share by Region (2021-2026) Table 33. Global Hematopoietic Stem Cells Transplantation Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Hematopoietic Stem Cells Transplantation Sales Value Share by Region (2027-2032) Table 35. Global Hematopoietic Stem Cells Transplantation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Hematopoietic Stem Cells Transplantation Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Hematopoietic Stem Cells Transplantation Sales Value Market Share by Country (2021-2026) Table 38. Global Hematopoietic Stem Cells Transplantation Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Hematopoietic Stem Cells Transplantation Sales Value Market Share by Country (2027-2032) Table 40. CBR Systems Company Information Table 41. CBR Systems Business Overview Table 42. CBR Systems Hematopoietic Stem Cells Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. CBR Systems Hematopoietic Stem Cells Transplantation Product Portfolio Table 44. CBR Systems Recent Development Table 45. China Cord Blood Corporation Company Information Table 46. China Cord Blood Corporation Business Overview Table 47. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product Portfolio Table 49. China Cord Blood Corporation Recent Development Table 50. ViaCord Company Information Table 51. ViaCord Business Overview Table 52. ViaCord Hematopoietic Stem Cells Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. ViaCord Hematopoietic Stem Cells Transplantation Product Portfolio Table 54. ViaCord Recent Development Table 55. Thermo Fisher Scientific Company Information Table 56. Thermo Fisher Scientific Business Overview Table 57. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product Portfolio Table 59. Thermo Fisher Scientific Recent Development Table 60. STEMCELL Technologies Company Information Table 61. STEMCELL Technologies Business Overview Table 62. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product Portfolio Table 64. STEMCELL Technologies Recent Development Table 65. Vcanbio Company Information Table 66. Vcanbio Business Overview Table 67. Vcanbio Hematopoietic Stem Cells Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Vcanbio Hematopoietic Stem Cells Transplantation Product Portfolio Table 69. Vcanbio Recent Development Table 70. Merck Millipore Company Information Table 71. Merck Millipore Business Overview Table 72. Merck Millipore Hematopoietic Stem Cells Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Merck Millipore Hematopoietic Stem Cells Transplantation Product Portfolio Table 74. Merck Millipore Recent Development Table 75. Lonza Group Company Information Table 76. Lonza Group Business Overview Table 77. Lonza Group Hematopoietic Stem Cells Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Lonza Group Hematopoietic Stem Cells Transplantation Product Portfolio Table 79. Lonza Group Recent Development Table 80. CellGenix Technologie Transfer Company Information Table 81. CellGenix Technologie Transfer Business Overview Table 82. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product Portfolio Table 84. CellGenix Technologie Transfer Recent Development Table 85. ThermoGenesis Company Information Table 86. ThermoGenesis Business Overview Table 87. ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. ThermoGenesis Hematopoietic Stem Cells Transplantation Product Portfolio Table 89. ThermoGenesis Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Hematopoietic Stem Cells Transplantation Product Image Figure 2. Global Hematopoietic Stem Cells Transplantation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hematopoietic Stem Cells Transplantation Market Size (2021-2032) & (US$ Million) Figure 4. Global Hematopoietic Stem Cells Transplantation Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Stem Cells Storage Image Figure 8. Stem Cells Consumables Image Figure 9. Global Hematopoietic Stem Cells Transplantation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Hematopoietic Stem Cells Transplantation Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Hematopoietic Stem Cells Transplantation Sales Value Share by Type (2021-2032) Figure 12. Leukemia Image Figure 13. Lymphoproliferative Disorders Image Figure 14. Solid Tumors Image Figure 15. Non-Malignant Disorders Image Figure 16. Global Hematopoietic Stem Cells Transplantation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Hematopoietic Stem Cells Transplantation Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Hematopoietic Stem Cells Transplantation Sales Value Share by Application (2021-2032) Figure 19. Global Hematopoietic Stem Cells Transplantation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Hematopoietic Stem Cells Transplantation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Hematopoietic Stem Cells Transplantation Sales Value (2021-2032) & (US$ Million) Figure 22. North America Hematopoietic Stem Cells Transplantation Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Hematopoietic Stem Cells Transplantation Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Hematopoietic Stem Cells Transplantation Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Hematopoietic Stem Cells Transplantation Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Hematopoietic Stem Cells Transplantation Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Hematopoietic Stem Cells Transplantation Sales Value (2021-2032) & (US$ Million) Figure 28. South America Hematopoietic Stem Cells Transplantation Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Hematopoietic Stem Cells Transplantation Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Hematopoietic Stem Cells Transplantation Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cells Storage
  • Stem Cells Consumables
Applications
  • Leukemia
  • Lymphoproliferative Disorders
  • Solid Tumors
  • Non-Malignant Disorders
Companies covered
  • CBR Systems
  • China Cord Blood Corporation
  • ViaCord
  • Thermo Fisher Scientific
  • STEMCELL Technologies
  • Vcanbio
  • Merck Millipore
  • Lonza Group
  • CellGenix Technologie Transfer
  • ThermoGenesis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hematopoietic Stem Cells Transplantation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Hematopoietic Stem Cells Transplantation Market Dynamics
  1. 2.1 Hematopoietic Stem Cells Transplantation Industry Trends
  2. 2.2 Hematopoietic Stem Cells Transplantation Industry Drivers
  3. 2.3 Hematopoietic Stem Cells Transplantation Industry Opportunities and Challenges
  4. 2.4 Hematopoietic Stem Cells Transplantation Industry Restraints
3 Hematopoietic Stem Cells Transplantation Market by Company
  1. 3.1 Global Hematopoietic Stem Cells Transplantation Company Revenue Ranking in 2025
  2. 3.2 Global Hematopoietic Stem Cells Transplantation Revenue by Company (2021-2026)
  3. 3.3 Global Hematopoietic Stem Cells Transplantation Company Ranking (2024-2026)
  4. 3.4 Global Hematopoietic Stem Cells Transplantation Company Manufacturing Base and Headquarters
  5. 3.5 Global Hematopoietic Stem Cells Transplantation Company Product Type and Application
  6. 3.6 Global Hematopoietic Stem Cells Transplantation Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Hematopoietic Stem Cells Transplantation Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Hematopoietic Stem Cells Transplantation Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Hematopoietic Stem Cells Transplantation Market by Type
  1. 4.1 Hematopoietic Stem Cells Transplantation Type Introduction
  2. 4.1.1 Stem Cells Storage
  3. 4.1.2 Stem Cells Consumables
  4. 4.2 Global Hematopoietic Stem Cells Transplantation Sales Value by Type
  5. 4.2.1 Global Hematopoietic Stem Cells Transplantation Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hematopoietic Stem Cells Transplantation Sales Value by Type (2021-2032)
  7. 4.2.3 Global Hematopoietic Stem Cells Transplantation Sales Value Share by Type (2021-2032)
5 Hematopoietic Stem Cells Transplantation Market by Application
  1. 5.1 Hematopoietic Stem Cells Transplantation Application Introduction
  2. 5.1.1 Leukemia
  3. 5.1.2 Lymphoproliferative Disorders
  4. 5.1.3 Solid Tumors
  5. 5.1.4 Non-Malignant Disorders
  6. 5.2 Global Hematopoietic Stem Cells Transplantation Sales Value by Application
  7. 5.2.1 Global Hematopoietic Stem Cells Transplantation Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Hematopoietic Stem Cells Transplantation Sales Value by Application (2021-2032)
  9. 5.2.3 Global Hematopoietic Stem Cells Transplantation Sales Value Share by Application (2021-2032)
6 Hematopoietic Stem Cells Transplantation Regional Value Analysis
  1. 6.1 Global Hematopoietic Stem Cells Transplantation Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hematopoietic Stem Cells Transplantation Sales Value by Region (2021-2032)
  3. 6.2.1 Global Hematopoietic Stem Cells Transplantation Sales Value by Region: 2021-2026
  4. 6.2.2 Global Hematopoietic Stem Cells Transplantation Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hematopoietic Stem Cells Transplantation Sales Value (2021-2032)
  7. 6.3.2 North America Hematopoietic Stem Cells Transplantation Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Hematopoietic Stem Cells Transplantation Sales Value (2021-2032)
  10. 6.4.2 Europe Hematopoietic Stem Cells Transplantation Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Hematopoietic Stem Cells Transplantation Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Hematopoietic Stem Cells Transplantation Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Hematopoietic Stem Cells Transplantation Sales Value (2021-2032)
  16. 6.6.2 South America Hematopoietic Stem Cells Transplantation Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Hematopoietic Stem Cells Transplantation Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Hematopoietic Stem Cells Transplantation Sales Value Share by Country, 2025 VS 2032
7 Hematopoietic Stem Cells Transplantation Country-level Value Analysis
  1. 7.1 Global Hematopoietic Stem Cells Transplantation Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hematopoietic Stem Cells Transplantation Sales Value by Country (2021-2032)
  3. 7.2.1 Global Hematopoietic Stem Cells Transplantation Sales Value by Country (2021-2026)
  4. 7.2.2 Global Hematopoietic Stem Cells Transplantation Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Hematopoietic Stem Cells Transplantation Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Hematopoietic Stem Cells Transplantation Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Hematopoietic Stem Cells Transplantation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CBR Systems
  2. 8.1.1 CBR Systems Company Information
  3. 8.1.2 CBR Systems Business Overview
  4. 8.1.3 CBR Systems Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CBR Systems Hematopoietic Stem Cells Transplantation Product Portfolio
  6. 8.1.5 CBR Systems Recent Developments
  7. 8.2 China Cord Blood Corporation
  8. 8.2.1 China Cord Blood Corporation Company Information
  9. 8.2.2 China Cord Blood Corporation Business Overview
  10. 8.2.3 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  11. 8.2.4 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product Portfolio
  12. 8.2.5 China Cord Blood Corporation Recent Developments
  13. 8.3 ViaCord
  14. 8.3.1 ViaCord Company Information
  15. 8.3.2 ViaCord Business Overview
  16. 8.3.3 ViaCord Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ViaCord Hematopoietic Stem Cells Transplantation Product Portfolio
  18. 8.3.5 ViaCord Recent Developments
  19. 8.4 Thermo Fisher Scientific
  20. 8.4.1 Thermo Fisher Scientific Company Information
  21. 8.4.2 Thermo Fisher Scientific Business Overview
  22. 8.4.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product Portfolio
  24. 8.4.5 Thermo Fisher Scientific Recent Developments
  25. 8.5 STEMCELL Technologies
  26. 8.5.1 STEMCELL Technologies Company Information
  27. 8.5.2 STEMCELL Technologies Business Overview
  28. 8.5.3 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  29. 8.5.4 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product Portfolio
  30. 8.5.5 STEMCELL Technologies Recent Developments
  31. 8.6 Vcanbio
  32. 8.6.1 Vcanbio Company Information
  33. 8.6.2 Vcanbio Business Overview
  34. 8.6.3 Vcanbio Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vcanbio Hematopoietic Stem Cells Transplantation Product Portfolio
  36. 8.6.5 Vcanbio Recent Developments
  37. 8.7 Merck Millipore
  38. 8.7.1 Merck Millipore Company Information
  39. 8.7.2 Merck Millipore Business Overview
  40. 8.7.3 Merck Millipore Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Millipore Hematopoietic Stem Cells Transplantation Product Portfolio
  42. 8.7.5 Merck Millipore Recent Developments
  43. 8.8 Lonza Group
  44. 8.8.1 Lonza Group Company Information
  45. 8.8.2 Lonza Group Business Overview
  46. 8.8.3 Lonza Group Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lonza Group Hematopoietic Stem Cells Transplantation Product Portfolio
  48. 8.8.5 Lonza Group Recent Developments
  49. 8.9 CellGenix Technologie Transfer
  50. 8.9.1 CellGenix Technologie Transfer Company Information
  51. 8.9.2 CellGenix Technologie Transfer Business Overview
  52. 8.9.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product Portfolio
  54. 8.9.5 CellGenix Technologie Transfer Recent Developments
  55. 8.10 ThermoGenesis
  56. 8.10.1 ThermoGenesis Company Information
  57. 8.10.2 ThermoGenesis Business Overview
  58. 8.10.3 ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ThermoGenesis Hematopoietic Stem Cells Transplantation Product Portfolio
  60. 8.10.5 ThermoGenesis Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst